Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Tetherin has negligible activity in restricting hepatitis C virus in hepatocytes.

Ye L, Wang X, Li J, Liu J, Ramirez SH, Wu J, Ho W.

Innate Immun. 2012 Jun;18(3):398-405. doi: 10.1177/1753425911412984. Epub 2011 Sep 22.

2.

Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin.

Dafa-Berger A, Kuzmina A, Fassler M, Yitzhak-Asraf H, Shemer-Avni Y, Taube R.

Virology. 2012 Jul 5;428(2):98-111. doi: 10.1016/j.virol.2012.03.011. Epub 2012 Apr 20.

3.

CAML does not modulate tetherin-mediated restriction of HIV-1 particle release.

Ali MS, Hammonds J, Ding L, Spearman P.

PLoS One. 2010 Feb 2;5(2):e9005. doi: 10.1371/journal.pone.0009005.

4.

BST-2 expression in human hepatocytes is inducible by all three types of interferons and restricts production of hepatitis C virus.

Amet T, Byrd D, Hu N, Sun Q, Li F, Zhao Y, Hu S, Grantham A, Yu Q.

Curr Mol Med. 2014 Mar;14(3):349-60.

PMID:
24236455
5.

Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.

Wang Y, Ye L, Wang X, Li J, Song L, Ho W.

Innate Immun. 2013;19(2):193-202. doi: 10.1177/1753425912460414. Epub 2012 Oct 11.

6.

The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.

Yan R, Zhao X, Cai D, Liu Y, Block TM, Guo JT, Guo H.

J Virol. 2015 Sep;89(18):9200-12. doi: 10.1128/JVI.00933-15. Epub 2015 Jun 24.

7.

CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes.

Ye L, Wang X, Wang S, Wang Y, Song L, Hou W, Zhou L, Li H, Ho W.

Hepatology. 2009 Mar;49(3):753-62. doi: 10.1002/hep.22715.

8.

Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes.

Aly HH, Watashi K, Hijikata M, Kaneko H, Takada Y, Egawa H, Uemoto S, Shimotohno K.

J Hepatol. 2007 Jan;46(1):26-36. Epub 2006 Oct 30.

PMID:
17112629
9.

Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.

Gupta RK, Hué S, Schaller T, Verschoor E, Pillay D, Towers GJ.

PLoS Pathog. 2009 May;5(5):e1000443. doi: 10.1371/journal.ppat.1000443. Epub 2009 May 22.

10.

Transmembrane interactions of HIV-1 Vpu and tetherin.

Guo F, Liang C.

Curr HIV Res. 2012 Jun;10(4):292-7. Review.

PMID:
22524177
11.

HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.

Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, Piguet V.

PLoS Pathog. 2009 Sep;5(9):e1000574. doi: 10.1371/journal.ppat.1000574. Epub 2009 Sep 4.

12.
13.

Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.

Lopez LA, Yang SJ, Exline CM, Rengarajan S, Haworth KG, Cannon PM.

J Virol. 2012 May;86(10):5467-80. doi: 10.1128/JVI.06280-11. Epub 2012 Mar 7.

14.

Vpu downmodulates two distinct targets, tetherin and gibbon ape leukemia virus envelope, through shared features in the Vpu cytoplasmic tail.

Lucas TM, Janaka SK, Stephens EB, Johnson MC.

PLoS One. 2012;7(12):e51741. doi: 10.1371/journal.pone.0051741. Epub 2012 Dec 19.

15.

Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes.

Wang Y, Li J, Wang X, Ye L, Zhou Y, Ho W.

J Viral Hepat. 2013 Jun;20(6):385-94. doi: 10.1111/jvh.12040. Epub 2013 Jan 7.

16.

Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes.

Ye L, Wang S, Wang X, Zhou Y, Li J, Persidsky Y, Ho W.

Drug Alcohol Depend. 2010 Nov 1;112(1-2):107-16. doi: 10.1016/j.drugalcdep.2010.05.008. Epub 2010 Jun 20.

17.

The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation.

Janvier K, Pelchen-Matthews A, Renaud JB, Caillet M, Marsh M, Berlioz-Torrent C.

PLoS Pathog. 2011 Feb 3;7(2):e1001265. doi: 10.1371/journal.ppat.1001265.

18.

Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.

Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, Fofana IB, Johnson WE, Westmoreland S, Evans DT.

PLoS Pathog. 2009 May;5(5):e1000429. doi: 10.1371/journal.ppat.1000429. Epub 2009 May 15.

19.

Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.

Vigan R, Neil SJ.

J Virol. 2010 Dec;84(24):12958-70. doi: 10.1128/JVI.01699-10. Epub 2010 Oct 6.

20.

Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.

Nandakumar R, Finsterbusch K, Lipps C, Neumann B, Grashoff M, Nair S, Hochnadel I, Lienenklaus S, Wappler I, Steinmann E, Hauser H, Pietschmann T, Kröger A.

Gastroenterology. 2013 Dec;145(6):1414-23.e1. doi: 10.1053/j.gastro.2013.08.037. Epub 2013 Aug 21.

PMID:
23973921
Items per page

Supplemental Content

Write to the Help Desk